VAM
AGN

Veritas Asset Management’s Allergan Inc AGN Stock Holding History

Veritas Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,397,600
Closed -$297M – 31
2014
Q4 		$297M Sell
1,397,600
-25,800
-2% -$5.13M 4.7% 13
2014
Q3 		$254M Hold
1,423,400
– – 4.05% 13
2014
Q2 		$241M Sell
1,423,400
-884,400
-38% -$138M 4.07% 13
2014
Q1 		$286M Sell
2,307,800
-16,400
-0.7% -$2M 5.09% 9
2013
Q4 		$258M Buy
2,324,200
+1,243,900
+115% +$119M 5.21% 8
2013
Q3 		$97.7M Buy
1,080,300
+39,300
+4% +$3.53M 2.31% 14
2013
Q2 		$87.7M Buy
+1,041,000
New +$108M 2.09% 14

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Veritas Asset Management's AGN Position: Q1 2015 in Review

Veritas Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,397,600 shares — an estimated $297M sold.

Veritas Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $297M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Veritas Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Veritas Asset Management sold 1,397,600 Allergan Inc shares in Q1 2015, an estimated $297M.
  • Veritas Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Veritas Asset Management's Allergan Inc position peaked at $297M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Veritas Asset Management's 13F filing for Q1 2015, filed 7 May 2015.